» Articles » PMID: 23150892

Development of Isotope Labeling LC-MS for Human Salivary Metabolomics and Application to Profiling Metabolome Changes Associated with Mild Cognitive Impairment

Overview
Journal Anal Chem
Specialty Chemistry
Date 2012 Nov 16
PMID 23150892
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Saliva is a readily available biofluid that may contain metabolites of interest for diagnosis and prognosis of diseases. In this work, a differential (13)C/(12)C isotope dansylation labeling method, combined with liquid chromatography Fourier transform ion cyclotron resonance mass spectrometry (LC-FTICR-MS), is described for quantitative profiling of the human salivary metabolome. New strategies are presented to optimize the sample preparation and LC-MS detection processes. The strategies allow the use of as little of 5 μL of saliva sample as a starting material to determine the concentration changes of an average of 1058 ion pairs or putative metabolites in comparative saliva samples. The overall workflow consists of several steps including acetone-induced protein precipitation, (12)C-dansylation labeling of the metabolites, and LC-UV measurement of the total concentration of the labeled metabolites in individual saliva samples. A pooled sample was prepared from all the individual samples and labeled with (13)C-dansylation to serve as a reference. Using this metabolome profiling method, it was found that compatible metabolome results could be obtained after saliva samples were stored in tubes normally used for genetic material collection at room temperature, -20 °C freezer, and -80 °C freezer over a period of 1 month, suggesting that many saliva samples already collected in genomic studies could become a valuable resource for metabolomics studies, although the effect of much longer term of storage remains to be determined. Finally, the developed method was applied for analyzing the metabolome changes of two different groups: normal healthy older adults and comparable older adults with mild cognitive impairment (MCI). Top-ranked 18 metabolites successfully distinguished the two groups, among which seven metabolites were putatively identified while one metabolite, taurine, was definitively identified.

Citing Articles

Guidelines for the standardization of pre-analytical variables for salivary biomarker studies in Alzheimer's disease research: An updated review and consensus of the Salivary Biomarkers for Dementia Research Working Group.

Ng T, Udeh-Momoh C, Lim M, Gleerup H, Leifert W, Ajalo C Alzheimers Dement. 2024; 21(2):e14420.

PMID: 39737743 PMC: 11848381. DOI: 10.1002/alz.14420.


The Potential of Metabolomics to Find Proper Biomarkers for Addressing the Neuroprotective Efficacy of Drugs Aimed at Delaying Parkinson's and Alzheimer's Disease Progression.

Franco R, Garrigos C, Lillo J, Rivas-Santisteban R Cells. 2024; 13(15.

PMID: 39120318 PMC: 11311351. DOI: 10.3390/cells13151288.


Non-invasive Biomarkers for Early Detection of Alzheimer's Disease: a New-Age Perspective.

Chimthanawala N, Haria A, Sathaye S Mol Neurobiol. 2023; 61(1):212-223.

PMID: 37596437 DOI: 10.1007/s12035-023-03578-3.


Salivary Metabolomics in the Diagnosis and Monitoring of Neurodegenerative Dementia.

Hyvarinen E, Solje E, Vepsalainen J, Kullaa A, Tynkkynen T Metabolites. 2023; 13(2).

PMID: 36837852 PMC: 9968225. DOI: 10.3390/metabo13020233.


Rapid ex vivo molecular fingerprinting of biofluids using laser-assisted rapid evaporative ionization mass spectrometry.

Plekhova V, Van Meulebroek L, De Graeve M, Perdones-Montero A, De Spiegeleer M, De Paepe E Nat Protoc. 2021; 16(9):4327-4354.

PMID: 34341579 DOI: 10.1038/s41596-021-00580-8.


References
1.
Birdsall T . Therapeutic applications of taurine. Altern Med Rev. 1998; 3(2):128-36. View

2.
Pesek J, Matyska M, Loo J, Fischer S, Sana T . Analysis of hydrophilic metabolites in physiological fluids by HPLC-MS using a silica hydride-based stationary phase. J Sep Sci. 2009; 32(13):2200-8. DOI: 10.1002/jssc.200900270. View

3.
Albert M, DeKosky S, Dickson D, Dubois B, Feldman H, Fox N . The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7(3):270-9. PMC: 3312027. DOI: 10.1016/j.jalz.2011.03.008. View

4.
Castagnola M, Cabras T, Iavarone F, Fanali C, Nemolato S, Peluso G . The human salivary proteome: a critical overview of the results obtained by different proteomic platforms. Expert Rev Proteomics. 2012; 9(1):33-46. DOI: 10.1586/epr.11.77. View

5.
Pfaffe T, Cooper-White J, Beyerlein P, Kostner K, Punyadeera C . Diagnostic potential of saliva: current state and future applications. Clin Chem. 2011; 57(5):675-87. DOI: 10.1373/clinchem.2010.153767. View